| Primary |
| Developmental Glaucoma |
100.0% |
|
| Toxicity To Various Agents |
100.0% |
|
| Secondary |
| Developmental Glaucoma |
24.3% |
| Drug Use For Unknown Indication |
17.1% |
| Glaucoma |
10.0% |
| Intraocular Pressure Increased |
8.6% |
| Pyrexia |
8.6% |
| Cough |
4.3% |
| Ocular Hypertension |
4.3% |
| Asthma |
2.9% |
| Intraocular Pressure Test |
2.9% |
| Osteoporosis |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Abdominal Pain Upper |
1.4% |
| Age-related Macular Degeneration |
1.4% |
| Cardiovascular Insufficiency |
1.4% |
| Constipation |
1.4% |
| Diarrhoea |
1.4% |
| Macular Degeneration |
1.4% |
| Plasma Cell Myeloma |
1.4% |
| Uveitis |
1.4% |
|
| Intraocular Pressure Increased |
15.8% |
| Pyrexia |
15.8% |
| Toxicity To Various Agents |
15.8% |
| Wheezing |
15.8% |
| Asthma |
5.3% |
| Deep Vein Thrombosis |
5.3% |
| Depressed Level Of Consciousness |
5.3% |
| Inappropriate Schedule Of Drug Administration |
5.3% |
| Ocular Hypertension |
5.3% |
| Rash Vesicular |
5.3% |
| Stupor |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.8% |
| Drug Use For Unknown Indication |
17.7% |
| Glaucoma |
14.3% |
| Hypertension |
7.9% |
| Rheumatoid Arthritis |
4.1% |
| Depression |
3.0% |
| Pain |
2.5% |
| Anxiety |
2.3% |
| Diabetes Mellitus |
2.2% |
| Sepsis |
1.8% |
| Arterial Occlusive Disease |
1.6% |
| Anaemia |
1.4% |
| Migraine |
1.4% |
| Open Angle Glaucoma |
1.4% |
| Osteoporosis |
1.4% |
| Atrial Fibrillation |
1.3% |
| Plasma Cell Myeloma |
1.3% |
| Renal Cell Carcinoma |
1.3% |
| Arthritis |
1.1% |
| Atrial Tachycardia |
1.1% |
|
| Intraocular Pressure Increased |
11.4% |
| Generalised Oedema |
8.6% |
| Aggression |
7.1% |
| Mobility Decreased |
7.1% |
| Myalgia |
7.1% |
| Syncope |
7.1% |
| Candidiasis |
4.3% |
| Circulatory Collapse |
4.3% |
| Drug Interaction |
4.3% |
| Lethargy |
4.3% |
| Resorption Bone Increased |
4.3% |
| Visual Acuity Reduced |
4.3% |
| Vocal Cord Paralysis |
4.3% |
| Vomiting |
4.3% |
| Acute Coronary Syndrome |
2.9% |
| Anaphylactic Reaction |
2.9% |
| Anterior Chamber Cell |
2.9% |
| Anterior Chamber Flare |
2.9% |
| Cataract |
2.9% |
| Drug Effect Decreased |
2.9% |
|
